The Indian Biotech industry is one of the key demand drivers for the technology providers (biosuppliers) whose major clientele are the R&D labs and manufacturing establishments. Though the biotech industry registered 18.5 percent growth over FY 2010-11, the biosuppliers industry recorded only a 15 percent growth. The biosuppliers in 2010-11 had registered a growth of 18.93 percent, but that growth rate declined during 2011-12 to 14.99 percent and the biosuppliers industry clocked Rs 5,324 crore in revenues as against previous year's revenue of Rs 4,630 crore.
The decline in the growth rate is attributed to depreciation of the rupee against greenback and subsequent increase in import costs. This has not only affected the overall revenues but made the market all the more competitive.
The biosuppliers industry has registered a Compound Annual Growth Rate (CAGR) of 32.62 percent during 2002-2006 and in the next five year period the industry witnessed a CAGR of 11.17 percent. The biosuppliers industry has registered a CAGR of 24.61 percent for the period 2002-11.
Though the biosuppliers industry has over 150 companies, multinationals have strong presence in India as they have been offering high quality products and services. The multinational companies (though less in number) account for over 73 percent of the total biosuppliers industry revenues and the rest of the revenues is generated by the local players (mainly the distributors).
While most of the principal companies have been generating an average revenue of over Rs 200 crore from the life sciences business operations in India, the local companies (mainly distributors) have been generating average revenues of Rs 40 crore with only a handful of them generating over Rs 100 crore.